MARKET

PCRX

PCRX

Pacira BioSciences Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

43.81
-0.13
-0.30%
After Hours: 44.10 +0.29 +0.66% 16:11 01/24 EST
OPEN
44.76
PREV CLOSE
43.94
HIGH
44.86
LOW
43.66
VOLUME
289.05K
TURNOVER
--
52 WEEK HIGH
49.50
52 WEEK LOW
34.64
MARKET CAP
1.83B
P/E (TTM)
834.48
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of PCRX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 15 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

PCRX News

  • RBC likes BioMarin in premarket analyst action
  • Seeking Alpha - Article.2d ago
  • SunTrust Robinson Humphrey Initiates Coverage On Pacira BioSciences with Buy Rating, Announces $60 Price Target
  • Benzinga.2d ago
  • Pacira Biosciences Shares Unaffected After Hours As Hearing SunTrust Initiated Stock With Buy Rating, $60 Price Target
  • Benzinga.2d ago
  • Heron Therapeutics (HRTX) Catches Eye: Stock Jumps 6.8%
  • Zacks.4d ago

More

Industry

Pharmaceuticals
-1.84%
Pharmaceuticals & Medical Research
-2.00%

Hot Stocks

Name
Price
%Change

About PCRX

Pacira BioSciences, Inc., formerly Pacira Pharmaceuticals, Inc. is a holding company. The Company is a pharmaceutical company focused on the development, manufacture and commercialization of pharmaceutical products, based on its DepoFoam extended release drug delivery technology, for use primarily in hospitals and ambulatory surgery centers. Its lead product candidate is EXPAREL (bupivacaine liposome injectable suspension), which consists of bupivacaine, an amide-type local anesthetic, encapsulated in DepoFoam and is indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. In addition to EXPAREL, DepoFoam is also the basis for its other Food and Drug Administration-approved commercial product, DepoCyt(e), which it manufactures for its commercial partners, as well as its product candidates. The Company's other product candidates include DepoMeloxicam (DepoMLX) and DepoTranexamic Acid (DepoTXA).
More

Webull offers Pacira Biosciences Inc (PCRX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.